KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

NCT03927495 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: KN046
RADIATION: palliative radiotherapy
DRUG: KN046

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]